Insulin glargine 300 U/mL safety data in pregnancy

被引：0
|
作者：
Westerbacka, Jukka [1 ]
Duverne, Marielle [1 ]
Grulovic, Natasa [1 ]
Thummisetti, Sreenivas [2 ]
Doder, Zoran [3 ]
机构：
[1] Sanofi, 46 Ave Grande, F-75017 Paris, France
[2] Sanofi, Hyderabad, India
[3] Sanofi, Bridgewater, MA USA
来源：
DIABETES OBESITY & METABOLISM | 2025年 / 27卷 / 05期
关键词：
gestational diabetes; glycaemic control; hypoglycaemia; insulin glargine; pregnancy; GLYCEMIC CONTROL; PERINATAL OUTCOMES; RANDOMIZED-TRIAL; ASPART; WOMEN; PROVIDES; DEGLUDEC; DETEMIR;
D O I：
10.1111/dom.16295
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2322 / 2325
页数：4
相关论文
共 50 条
  • [1] A review of the safety and efficacy data for insulin glargine 300 units/ml, a new formulation of insulin glargine
    Dailey, G.
    Lavernia, F.
    DIABETES OBESITY & METABOLISM, 2015, 17 (12): : 1107 - 1114
  • [2] Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
    Steinstraesser, A.
    Schmidt, R.
    Bergmann, K.
    Dahmen, R.
    Becker, R. H. A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (09): : 873 - 876
  • [3] Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats
    Saini, N. K.
    Wasik, B.
    Pires, J.
    Leale, D. M.
    Quach, N.
    Culp, W. T. N.
    Samms, R. J.
    Johnson, A. E.
    Owens, J. G.
    Gilor, C.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2021, 75
  • [4] Reported pregnancy outcomes with insulin glargine 300 U/mL: a post-marketing survey of pharmacovigilance data
    Westerbacka, J.
    Bassole, C.
    Duverne, M.
    Doder, Z.
    Schoepper, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [5] Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mL
    Jennifer N. Clements
    Tiffaney Threatt
    Eileen Ward
    Kayce M. Shealy
    Clinical Pharmacokinetics, 2017, 56 : 449 - 458
  • [6] Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus
    Blair, Hannah A.
    Keating, Gillian M.
    DRUGS, 2016, 76 (03) : 363 - 374
  • [7] Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mL
    Clements, Jennifer N.
    Threatt, Tiffaney
    Ward, Eileen
    Shealy, Kayce M.
    CLINICAL PHARMACOKINETICS, 2017, 56 (05) : 449 - 458
  • [8] Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2016, 76 : 363 - 374
  • [9] Reported Pregnancy Outcomes with Insulin Glargine 100 U/mL (Gla-100) and 300 U/mL (Gla-300) : Post-Marketing Survey of Pharmacovigilance Data
    Westerbacka, Jukka
    Bassole, Caroline
    Duverne, Marielle
    Doder, Zoran
    Schoepper, Heike
    DIABETES, 2022, 71
  • [10] Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus
    Linari, Guido
    Fleeman, Linda
    Gilor, Chen
    Giacomelli, Lucia
    Fracassi, Federico
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (02) : 168 - 176
12345